SEZI Senzime AB (publ)

0.3243USD3.295 SEK · STO-1.49%Mkt Cap: 50.99M USDP/E: —

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The compa…

Institutional holders1 on file

Key Statistics

Company
Market Cap50.99M USD
Enterprise Value50.22M USD
Revenue (TTM)10.47M USD
Gross Profit3.41M USD
Net Income (TTM)-13.53M USD
Revenue/Share0.07 USD
Last Price0.3243 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees59
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0002478776
Valuation
P/E (Trailing)—
P/E (Forward)-10.98
PEG—
EV/EBITDA-5.08
EV/Revenue4.80
P/S4.87
P/B2.04
EPS (TTM)-0.06 USD
EPS (Forward)-0.03 USD
52W Range
0.231326% of range0.5906
52W High0.5906 USD
52W Low0.2313 USD
Profitability
Gross Margin33.35%
Oper. Margin-95.70%
EBITDA Margin-94.47%
Profit Margin-132.11%
ROE-45.14%
ROA-37.03%
ROIC-48.48%
ROCE-35.70%
Growth
Revenue Growth13.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.74M USD
CapEx (TTM)1.78M USD
FCF Margin-39.11%
FCF Yield-8.03%
Net Debt-764.50K USD
Net Debt/EBITDA0.08
Net Debt/FCF—
Balance Sheet
Debt/Equity0.05
Current Ratio2.84
Quick Ratio1.77
Book Value/Sh0.16 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.7707 USD
Upside (mean)+137.6%
Target Range0.7707 USD – 0.7707 USD
# Analysts1
Ownership
Shares Out.157.22M
Float107.47M
Insiders42.38%
Institutions22.76%
Technical
SMA 500.2952 (+9.9%)
SMA 2000.3916 (-17.2%)
Beta0.45
S&P 52W Chg12.00%
Avg Vol (30d)519.15K
Avg Vol (10d)577.62K
Technical Indicators
RSI (14)52.5
MACD0.1219
MACD Signal0.1322
MACD Hist.-0.0103
BB Upper0.3795 USD
BB Middle0.3205 USD
BB Lower0.2615 USD
BB Width36.80%
ATR (14)0.0239 USD
Vol Ratio (20d)0.36x

About Senzime (STO: SEZI)

›

Senzime (STO: SEZI) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 59 employees.

The shares were at 3.295 SEK on 19 November 2026, down 38.9% over 52 weeks. Its 52-week range is 2.350 SEK to 6.000 SEK: the price is 45.1% below the high and 40.2% above the low.

Its market capitalisation is 518.02M SEK.

Senzime reports return on equity of -45.1%, an operating margin of -95.7% and revenue up 13.7% year over year.

It holds more cash than debt, a net cash position of 7.77M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 7.830 SEK is 137.6% above the current price. The next earnings report is expected on 28 January 2027.